Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-014453

RESMED INC · RMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Peter C Farrell
Officer — Chairman of the Board · Director
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 7:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
ResMed Common StockApr 1, 2015M13,557$15.52A382,156D
ResMed Common StockF3Apr 1, 2015S13,357$70.6881D368,799D
ResMed Common StockF4Apr 1, 2015S200$71.245D368,599D
ResMed Common StockApr 1, 2015M24,443$19.25A391,042D
ResMed Common StockF5Apr 1, 2015S22,143$70.6876D368,599D
ResMed Common StockF6Apr 1, 2015S300$71.28D368,599D
ResMed Common StockF7holding———22,783IPeter C. Farrell Grantor Retained Trust dated December 2012
ResMed Common StockF1holding———87,776IPeter C. Farrell Grantor Retained Annuity Trust dated March 4, 2014
Resmed Common StockF7holding———200,000IPeter C. Farrell Grantor Retained Annuity Trust dated October 14, 2014

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
ResMed Common Stock OptionsF2$15.52Apr 1, 2015M13,557DNov 20, 2009Nov 20, 2015ResMed Commmon Stock13,5570D
ResMed Common Stock OptionsF2$19.25Apr 1, 2015M22,443DFeb 3, 2007Feb 3, 2016ResMed Common Stock22,443207,169D

Explanation of responses